Cardiology
Conference Coverage
DAPA-CKD: SGLT2 inhibitor benefit extends to chronic kidney disease without diabetes
DAPA-CKD showed that dapagliflozin helps patients with albuminuria and declining eGFR levels whether or not they have type 2 diabetes.
Conference Coverage
RATE-AF trial boosts digoxin for rate control in permanent AFib
Study shows equally good rate control as with a beta-blocker, but with far fewer adverse events.
Latest News
COVID-19 at home: What does optimal care look like?
Most attention has focused on the sickest patients, leaving less severe cases to fall through the cracks.
Conference Coverage
Aspirin alone preferred antithrombotic strategy after TAVI
Aspirin alone after TAVI significantly reduced bleeding compared with aspirin plus clopidogrel, without increasing thromboembolic events, in the...
Conference Coverage
EMPEROR-Reduced: Empagliflozin’s HFrEF benefit solidifies class effects
Pearl of the Month
Vitamin D pearls
Risk factors for worse COVID-19 outcome are also risk factors for vitamin D deficiency.
From the Journals
Nine antihypertensive drugs associated with reduced risk of depression
Some but not all drugs in three antihypertensive classes are associated with reduced risk of depression.
From the Journals
FDA pulls amputation boxed warning off canagliflozin label
New safety information suggests the risk of amputation, while still increased with canagliflozin, is lower than previously described, particularly...
From the Journals
First evidence of SARS-CoV-2 in heart cells
SARS-CoV-2 has been found in cardiac tissue of a child with multisystem inflammatory syndrome related to COVID-19, believed to be first evidence...
News
FDA updates hydrochlorothiazide label to include nonmelanoma skin cancer risk
Patients should continue taking the antihypertensive drug unless their doctor says otherwise, according to an FDA...
Latest News
Humira topped drug-revenue list for 2019
Three cytokine inhibitors were among the four best-selling drugs last year.